Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

An alternative property for evaluating sample size for normal data using preliminary data

Clinical Trials

Impact Factor: 2.4 / 5-Year Impact Factor: 2.8

Journal Homepage Submission guidelines

Restricted access

Letter

First published online December, 2013

An alternative property for evaluating sample size for normal data using preliminary data

Volume 10, Issue 6

https://doi.org/10.1177/1740774513506965

Abstract

Get full access to this article

View all access options for this article.

References

1.

Chen

H

Zhang

N

Lu

X

Chen

S

. Caution regarding the choice of standard deviations to guide sample size calculations in clinical trials. Clin Trials2013; 10: 522–29.

2.

Fay

MP

Halloran

ME

Follman

DA

. Accounting for variability in sample size estimation with applications to nonadherence and estimation of variance and effect size. Biometrics2007; 63: 465–74.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Restricted access

How good does the science have to be in proposals submitted to Institutional Review Boards? An Interview Study of Institutional Review Board personnel

Restricted access

Prospective alpha allocation in the clarification of optimal anticoagulation through genetics (COAG) trial

Open access

Increasing the use of mobile technology–derived endpoints in clinical trials

Restricted access

Exclusion of people from oncology clinical trials based on functional status